Calcineurin Activity Assay Measurement by Liquid Chromatography–Tandem Mass Spectrometry in the Multiple Reaction Monitoring Mode
Open Access
- 1 February 2014
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 60 (2) , 353-360
Abstract
BACKGROUND: Blood concentrations of the calcineurin inhibitors (CNIs) cyclosporine and tacrolimus are currently measured to monitor immunosuppression in transplant patients. The measurement of calcineurin (CN) phosphatase activity has been proposed as a complementary pharmacodynamic approach. However, determining CN activity with current methods is not practical. We developed a new method amenable to routine use. METHODS: Using liquid chromatography–multiple reaction monitoring mass spectrometry (LC-MRM-MS), we quantified CN activity by measuring the dephosphorylation of a synthetic phosphopeptide substrate. A stable isotope analog of the product peptide served as internal standard, and a novel inhibitor cocktail minimized dephosphorylation by other major serine/threonine phosphatases. The assay was used to determine CN activity in peripheral blood mononuclear cells (PBMCs) isolated from 20 CNI-treated kidney transplant patients and 9 healthy volunteers. RESULTS: Linearity was observed from 0.16 to 2.5 μmol/L of product peptide, with accuracy in the 15% tolerance range. Intraassay and interassay recoveries were 100.6 (9.6) and 100 (7.5), respectively. Michaelis–Menten kinetics for purified CN were Km = 10.7 (1.6) μmol/L, Vmax = 2.8 (0.3) μmol/min · mg, and for Jurkat lysate, Km = 182.2 (118.0) μmol/L, Vmax = 0.013 (0.006) μmol/min · mg. PBMC CN activity was successfully measured in a single tube with an inhibitor cocktail. CONCLUSIONS: Because LC-MRM-MS is commonly used in routine clinical dosage of drugs, this CN activity assay could be applied, with parallel blood drug concentration monitoring, to a large panel of patients to reevaluate the validity of PBMC CN activity monitoring.Keywords
This publication has 21 references indexed in Scilit:
- Expression of Calcineurin Activity after Lung Transplantation: A 2-Year Follow-UpPLOS ONE, 2013
- Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial ResultsPLOS ONE, 2013
- Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinomaLiver International, 2009
- Pitfalls and Prevention Strategies for Liquid Chromatography-Tandem Mass Spectrometry in the Selected Reaction– Monitoring Mode for Drug AnalysisClinical Chemistry, 2008
- Pharmacokinetic-Pharmacodynamic Assessment of Tacrolimus in Liver-Transplant Recipients during the Early Post-Transplantation PeriodTherapeutic Drug Monitoring, 2008
- A fluorimetric method for determination of calcineurin activityCell Calcium, 2008
- Analysis of calcineurin activity by capillary electrophoresis with laser‐induced fluorescence detection using peptide substrateJournal of Separation Science, 2008
- Distribution of calcineurin activity in blood cell fractions and impact of tacrolimus inhibitionFundamental & Clinical Pharmacology, 2006
- Validation of the Calcineurin Phosphatase AssayClinical Chemistry, 2004
- Measurement of Calcineurin Phosphatase Activity in Cell ExtractsMethods, 1996